1Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [ J ]. Ann Intern Med, 2000,30 ( suppl2 ) : S171 - 176.
6Murri R, Ammassari A, De Luca A, et al. Self - reported nonadherence with antiretroviral drugs predicts persistent condition [J ].HIV Clin Trials, 2001,2:323 - 329.
7Descamps D, Flandre P, Calves V, et al. Mechanisms of virologic failure in previously untreated HIV-infeeted patients from a trial of induction-manintenance therapy.Trilege(Agence National de Recherches sur Ie SIDA 072)Study Team[J] .JAMA, 2000,283:205 - 211.
8Murri R,Ammassari A, Gallieano K, et al. Patient-reported nonadherence to ART is related to protease inhibitor levels[J]. J Acquuir Immune Defic Syndr, 2000,24 : 123 - 128.
9Montaner JS, Reiss P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial.Italy, The Netherlands, Canada and Australia Study[ J ]. JAMA, 1998,279 : 930 - 937.
10Gifford AL,Bormann JE,Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens[ J ]. J Acquir Immune Defic Syndr, 2000,23 : 386 - 395.
